242 related articles for article (PubMed ID: 28238813)
1. Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA.
Cheng THT; Jiang P; Tam JCW; Sun X; Lee WS; Yu SCY; Teoh JYC; Chiu PKF; Ng CF; Chow KM; Szeto CC; Chan KCA; Chiu RWK; Lo YMD
Clin Biochem; 2017 Jun; 50(9):496-501. PubMed ID: 28238813
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
[TBL] [Abstract][Full Text] [Related]
3. Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
Markus H; Zhao J; Contente-Cuomo T; Stephens MD; Raupach E; Odenheimer-Bergman A; Connor S; McDonald BR; Moore B; Hutchins E; McGilvrey M; de la Maza MC; Van Keuren-Jensen K; Pirrotte P; Goel A; Becerra C; Von Hoff DD; Celinski SA; Hingorani P; Murtaza M
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597261
[TBL] [Abstract][Full Text] [Related]
4. Digital Droplet PCR for Monitoring Tissue-Specific Cell Death Using DNA Methylation Patterns of Circulating Cell-Free DNA.
Shemer R; Magenheim J; Dor Y
Curr Protoc Mol Biol; 2019 Jun; 127(1):e90. PubMed ID: 31237424
[TBL] [Abstract][Full Text] [Related]
5. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.
Sun K; Jiang P; Chan KC; Wong J; Cheng YK; Liang RH; Chan WK; Ma ES; Chan SL; Cheng SH; Chan RW; Tong YK; Ng SS; Wong RS; Hui DS; Leung TN; Leung TY; Lai PB; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):E5503-12. PubMed ID: 26392541
[TBL] [Abstract][Full Text] [Related]
6. Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Lehmann-Werman R; Neiman D; Zemmour H; Moss J; Magenheim J; Vaknin-Dembinsky A; Rubertsson S; Nellgård B; Blennow K; Zetterberg H; Spalding K; Haller MJ; Wasserfall CH; Schatz DA; Greenbaum CJ; Dorrell C; Grompe M; Zick A; Hubert A; Maoz M; Fendrich V; Bartsch DK; Golan T; Ben Sasson SA; Zamir G; Razin A; Cedar H; Shapiro AM; Glaser B; Shemer R; Dor Y
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1826-34. PubMed ID: 26976580
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches.
Wong FC; Sun K; Jiang P; Cheng YK; Chan KC; Leung TY; Chiu RW; Lo YM
Clin Biochem; 2016 Dec; 49(18):1379-1386. PubMed ID: 27620950
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.
Grskovic M; Hiller DJ; Eubank LA; Sninsky JJ; Christopherson C; Collins JP; Thompson K; Song M; Wang YS; Ross D; Nelles MJ; Yee JP; Wilber JC; Crespo-Leiro MG; Scott SL; Woodward RN
J Mol Diagn; 2016 Nov; 18(6):890-902. PubMed ID: 27727019
[TBL] [Abstract][Full Text] [Related]
9. A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection.
Cheng AP; Burnham P; Lee JR; Cheng MP; Suthanthiran M; Dadhania D; De Vlaminck I
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18738-18744. PubMed ID: 31451660
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
[TBL] [Abstract][Full Text] [Related]
11. A novel urine cell-free DNA preservation solution and its application in kidney transplantation.
Zhou Q; Liu F; Guo L; Chen R; Yuan X; Li C; Shu L; Liu H; Zhou Y; Wu Y; Shi H; Zhao H; Jiang T
Nephrology (Carlton); 2021 Aug; 26(8):684-691. PubMed ID: 33866646
[TBL] [Abstract][Full Text] [Related]
12. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.
Ma X; Zhu L; Wu X; Bao H; Wang X; Chang Z; Shao YW; Wang Z
PLoS One; 2017; 12(1):e0169231. PubMed ID: 28046008
[TBL] [Abstract][Full Text] [Related]
14. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.
Ivanov M; Baranova A; Butler T; Spellman P; Mileyko V
BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S1. PubMed ID: 26693644
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA.
Worm Ørntoft MB; Jensen SØ; Hansen TB; Bramsen JB; Andersen CL
Epigenetics; 2017 Aug; 12(8):626-636. PubMed ID: 28557629
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis.
Kueng N; Sidler D; Banz V; Largiadèr CR; Ng CKY; Amstutz U
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568867
[TBL] [Abstract][Full Text] [Related]
17. [Practical stability of whole-genome bisulfite sequencing using plasma cell-free DNA].
Fang H; Zhong B; Wei L; Zhang X; Zhang W; Wang X
Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2284-2294. PubMed ID: 31880136
[TBL] [Abstract][Full Text] [Related]
18. Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract.
Burnham P; Dadhania D; Heyang M; Chen F; Westblade LF; Suthanthiran M; Lee JR; De Vlaminck I
Nat Commun; 2018 Jun; 9(1):2412. PubMed ID: 29925834
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage.
Tug S; Helmig S; Deichmann ER; Schmeier-Jürchott A; Wagner E; Zimmermann T; Radsak M; Giacca M; Simon P
Exerc Immunol Rev; 2015; 21():164-73. PubMed ID: 25826002
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measurement of cell-free plasma DNA and applications for detecting tumor genetic variation and promoter methylation in a clinical setting.
Kadam SK; Farmen M; Brandt JT
J Mol Diagn; 2012 Jul; 14(4):346-56. PubMed ID: 22579630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
